Antipodean Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$4.81M |
| 2 |
Occidental Petroleum
OXY
|
+$2.83M |
| 3 |
BRC Group Holdings
RILY
|
+$523K |
| 4 |
Digital Realty Trust
DLR
|
+$430K |
| 5 |
Trupanion
TRUP
|
+$426K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$2.26M |
| 2 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
+$525K |
| 3 |
Carvana
CVNA
|
+$259K |
| 4 |
Cardlytics
CDLX
|
+$195K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 33.24% |
| 2 | Consumer Staples | 23.72% |
| 3 | Consumer Discretionary | 15.76% |
| 4 | Healthcare | 9.75% |
| 5 | Miscellaneous | 6.66% |
Similar funds
Antipodean Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Antipodean Advisors held 15 positions worth $19.5M, up 38% from $14.1M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Antipodean Advisors deployed $6.52M of net new capital in Q3 2023, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was Philip Morris: 50,000 shares worth $4.63M.
By sector, the portfolio is most concentrated in Energy at 33% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was CareMax, Inc. Class A Common Stock, an estimated $525K trimmed.
- Antipodean Advisors's largest Q3 2023 buy was Philip Morris: 50,000 shares worth $4.63M.
- Antipodean Advisors added most to Occidental Petroleum in Q3 2023, an estimated $2.83M increase.
- Antipodean Advisors's biggest Q3 2023 reduction was CareMax, Inc. Class A Common Stock, cutting an estimated $525K.
- Antipodean Advisors fully exited VanEck Gold Miners ETF in Q3 2023, selling an estimated $2.26M.
- Antipodean Advisors's ten largest holdings make up 98% of its $19.5M portfolio in Q3 2023.
- Antipodean Advisors opened 7 new positions and closed 2 in Q3 2023.
- Antipodean Advisors's portfolio value rose 38% quarter-over-quarter to $19.5M.
Based on Antipodean Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.